ucrest founder is somebody.. don't underestimate this partnership..

if semiconductor is the miracle of the 1980s,
PC is for the 1990s,
Cloud Service is for the 2000s,

IOT is for the 21st.
uCrest falls into this category..

biotech and health is the next industry to be have to transformation.

the delay is caused by NPRA pending approval result. partly because i think is due to participating countries for sputnik is less "developed" and non-first-world aligned countries.

Duopharma, is somewhat more pressing.
Malaysia vaccination% is still very comparing to some neighbouring countries.
their willingness to pay premium prices, perhaps?
Their close geopolitcal proximity with usa maybe one of the reason to shun this vaccine.
if the existing data and vaccination result remain true, this vaccine with high efficacy and low side effect reported is a pretty good product. the latter is where NPRA may need more time to study.

as a Malaysian, I would say that all the time you need to study for the vaccine as to confirm it is safe for Malaysians.

as a shareholder of dpharma, i would comment that I would be proud that Dpharma is able to produce their own vaccine in-house and undertake R&D collaborations with World's bests.

We Malaysians are Capable of Great Things !

you say it is a joke because you have bought none of its share...mr eg kah yee he is no a joke...ucrest product the imedic is already entering many hospitals in china..and soon it will used imedic to monitor ones who receiving sputnik v..beside ucrest, keyasic too will get the benefit